Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Zentalis Pharmaceuticals (ZNTL) Receivables - Other (2022 - 2023)

Zentalis Pharmaceuticals (ZNTL) has 2 years of Receivables - Other data on record, last reported at $7.9 million in Q1 2023.

  • For Q1 2023, Receivables - Other rose 236.8% year-over-year to $7.9 million; the TTM value through Mar 2023 reached $7.9 million, up 236.8%, while the annual FY2022 figure was $5.9 million, N/A changed from the prior year.
  • Receivables - Other reached $7.9 million in Q1 2023 per ZNTL's latest filing, up from $5.9 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $7.9 million in Q1 2023 and bottomed at $2.3 million in Q1 2022.